$130 Million
Financial Advisor
Acquisition of Diagnostic Hybrids
January 2010
$97 Million
Sole Bookrunner
Follow-On
January 2010
$29 Million
Financial Advisor
Sale to Sciele (A Shionogi Company)
November 2009
$199 Million
Joint Bookrunner
Initial Public Offering
October 2009
$85 MILLION
Financial Advisor
Sale to Gen-Probe
October 2009
$49 Million
Sole Bookrunner
Follow-On
September 2009
$288 Million
Financial Advisor
Sale to Leo Pharma
September 2009
$68 Million
Financial Advisor
Merger with Candela
September 2009
$398 Million
Financial Advisor
Tender Offer to Acquire Facet Biotech
September 2009
$50 Million
Sole Agent
Private Placement
September 2009
$58 Million
Co-Manager
Follow-On
August 2009
$23 Million
Sole Bookrunner
Follow-On
August 2009